Science and technology firm Merck on Tuesday announced a support of 2 million euros (Rs 17.85 crore) for India to help the country fight against COVID-19.
The aid is being utilised for procuring 250 oxygen concentrators, 100 ventilators, and setting up of oxygen generation plants in four hospitals, Merck said in a statement.
Merck India is working with state governments, government departments and non-profit service organisations managing COVID care for putting this aid to use of people who may be needing it the most, it added.
A part of this aid will also be utilised to procure medicines for emergency care of employees and their families, Merck said.
"We are happy to extend this care and are confident that our aid will be supplementing the government's efforts in addressing the need of the patients," Sunil Punjabi, Country Speaker and Head of Research Solutions, Life Science, Merck said.
As part of its regular CSR activities, Merck had earlier donated over 1.6 lakh face masks, disinfectants and thermal temperature scanners to the frontline and health departments as well as dry rations to migrant workers' families around its manufacturing sites, Merck said.
The company has also contributed to the state relief funds in Karnataka and Maharashtra, and to the PM CARES fund, towards COVID relief, it added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)